| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.5 |